AOA in Recurrent Fertilization Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

November 17, 2018

Conditions
Infertility Primary
Interventions
DRUG

Calcium Ionophore A23187

"Calcium Ionophore A23187 is used in laboratories to increase intracellular Ca2+ levels in intact cells. It also uncouples oxidative phosphorylation, the process cells use to synthesize Adenosine triphosphate which they use for energy. In addition, A23187 inhibits mitochondrial ATPase activity. A23187 also induces apoptosis in some cells (e.g. mouse lymphoma cell line, or S49, and Jurkat cells) and prevents it in others (e.g. cells dependent on interleukin 3 that have had the factor withdrawn).~In IVF field, Ca Ionophore can be used in case of low fertilization rate after ICSI procedure, particularly with Globozoospermia (Round Head sperm syndrome), Ca Ionophore will replace absence of sperm acrosom, and plays role in oocyte activation after ICSI. Recommended use is 0.5 microgram/ml twice for 10 min interrupted with fresh media with 30 min incubation, followed with regular injected eggs culture for IVF."

Trial Locations (1)

17151

Al-Azhar University, Cairo

All Listed Sponsors
lead

MOHAMED BEHERY

OTHER

NCT04744753 - AOA in Recurrent Fertilization Failure | Biotech Hunter | Biotech Hunter